Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Gut|February 24, 2022
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classificationCarla Montironi, Florian Castet, Philipp K Haber, et al.Molecular Cancer Therapeutics|February 13, 2023
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in HepatoblastomaJordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2022
Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental AgentsLaura Torrens, Marc Puigvehí, Miguel Torres-Martín, et al.JHEP Reports : Innovation in Hepatology|April 28, 2025
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesisKornelius Schulze, Tim Daniel Rose, Lorenz Adlung, et al.Gastroenterology|September 15, 2022
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular CarcinomaPhilipp K Haber, Florian Castet, Miguel Torres-Martin, et al.Journal of Hepatology|December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.Gut|April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapyJack Leslie, John B G Mackey, Thomas Jamieson, et al.Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.Pageof 9